Stable nanoemulsions for poorly soluble curcumin: From production to digestion response in vitro

Curcumin, a polyphenol, can induce anticancer activity depending on dose. However, oral curcumin administration is limited by its low bioavailability due to aqueous insolubility and instability against physiological conditions. This study aims at formulating nanoemulsions by phase inversion temperature to enhance curcumin loading, stability, antioxidant performance, bioaccessibility, and in vitro absorption. The selection mechanisms for oil phase (coconut oil), surfactant (polyoxyl 40 hydrogenated castor oil), co-surfactant (soy phospholipid), and aqueous phase (2 % wt citrate buffer at pH 4.5) are established. The nanoemulsions show tunable mean droplet size (26–129 nm), high curcumin loading (9.53 ± 0.49 mg/mL), polydispersity < 0.3, and ζ-potential < -26 mV. Nanoencapsulation increases curcumin photostability by 36–42 % and the antioxidant activity after 24-hour UV radiation is unchanged (P > 0.05). The curcumin nanoemulsions show ∼ 11 %, 24 %, and 57 % higher retention and ∼ 10 %, 12 %, and 17 % higher antioxidant activity than raw curcumin after 3-hour simulated gastric, intestinal, and physiological incubations, respectively. During in vitro digestion and absorption, the encapsulated curcumin shows higher bioaccessibility and absorption than free curcumin (P < 0.05). The samples are stable during 4-week storage at 4˚C and room temperature without preservatives. These findings suggest the potential to develop a nanoencapsulation strategy, particularly for an oral delivery system of oil-soluble drugs.